Aristotle Atlantic Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Aristotle Atlantic Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,500	Closed	-$325K	–	104
2021 Q1	$325K	Buy	+1,500	New	+$282K	0.02%	91
2019 Q3	–	Sell	-1,250	Closed	-$215K	–	99
2019 Q2	$215K	Buy	+1,250	New	+$216K	0.06%	90

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Aristotle Atlantic Partners's GWPH Position: Q2 2021 in Review

Aristotle Atlantic Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,500 shares — an estimated $325K sold.

Aristotle Atlantic Partners first reported a position in GWPH in Q2 2019 and held it in 2 quarters. The position peaked at $325K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Aristotle Atlantic Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Aristotle Atlantic Partners sold 1,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $325K.
Aristotle Atlantic Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 2 quarters.
Aristotle Atlantic Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $325K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2021, filed 16 Aug 2021.